Participants 80 118 3
age related macular degeneration (AMD)
Participants 542 725 6
Patients that had nonexudative age-related macular degeneration (AMD) and certain hemorheologic abnormalities were randomized to either rheopheresis or sham treatment in a 2:1 fashion
Participants 872 912 5
A total of 216 patients were randomized.
